Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

314
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
314
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

172
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
172
Antibiotic Selection00:57

Antibiotic Selection

62.5K
Overview
62.5K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

66
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
66
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

2.1K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.1K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

2.1K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canada's "American-style" dental health system.

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada·2026
Same author

Commentary-presentation and reflections on renewing Canada's public health core competencies.

Canadian journal of public health = Revue canadienne de sante publique·2026
Same author

Increasing rates of Chlamydia trachomatis infection in Alberta, Saskatchewan, and Manitoba compared to Canada overall, between 1991 and 2022.

Infectious diseases now·2026
Same author

Enumeration, Phenotyping, and Clinical Associations of Tissue-Resident T Cells in the Ecto- and Endocervix of Women Attending a Colposcopy Clinic.

American journal of reproductive immunology (New York, N.Y. : 1989)·2026
Same author

Trauma, empowerment, and resilience: understanding the mental health concerns of people living with human immunodeficiency virus in Manitoba.

Frontiers in public health·2026
Same author

Epidemiology of hepatitis C in Alberta, Saskatchewan, and Manitoba compared to Canada, 1980-2023.

Journal of infection and public health·2026
Same journal

Long COVID and health-related quality of life: a systematic review of immune, inflammatory, and metabolic markers.

Frontiers in public health·2026
Same journal

Smart wearables for school-based physical activity promotion: K-12 physical education teachers' continuance intention and adoption pathways.

Frontiers in public health·2026
Same journal

Acceptance of an upper body exoskeleton for occupational tasks among soldiers.

Frontiers in public health·2026
Same journal

Effectiveness of a perforated spoon for reducing salt intake in a university cafeteria.

Frontiers in public health·2026
Same journal

Association of psychological resilience and social support with subjective coercion experience in hospitalized psychiatric inpatients: a cross-sectional study.

Frontiers in public health·2026
Same journal

The "5-4-3" model for weight management in psychiatric inpatients: a single-arm pre-post evaluation.

Frontiers in public health·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.8K

Vancomycin revisited - 60 years later.

Ethan Rubinstein1, Yoav Keynan1

  • 1Department of Internal Medicine, University of Manitoba , Winnipeg, MB , Canada.

Frontiers in Public Health
|November 18, 2014
PubMed
Summary
This summary is machine-generated.

Vancomycin, an antibiotic used for nearly 60 years, remains crucial for treating Gram-positive infections like MRSA. While generally safe, vigilance against rising resistance and potential nephrotoxicity is essential for its continued effectiveness.

Keywords:
MRSAVREdosenephrotoxicityoral-vancomycinsafetyvancomycin“red man” syndrome

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

2.0K
A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

30.0K

Related Experiment Videos

Last Updated: Apr 20, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.8K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

2.0K
A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

30.0K

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Vancomycin has been clinically utilized for approximately 60 years.
  • Early vancomycin formulations were associated with significant vestibular and renal toxicities due to impurities.
  • Modern vancomycin purification has reduced vestibular side effects, but nephrotoxicity remains a concern at high doses or prolonged use.

Purpose of the Study:

  • To review the current clinical applications of vancomycin.
  • To discuss the evolving landscape of vancomycin resistance, particularly in Staphylococcus aureus.
  • To highlight the safety profile and adverse events associated with vancomycin therapy.

Main Methods:

  • Literature review of vancomycin's historical use, efficacy, and safety.
  • Analysis of current trends in vancomycin Minimum Inhibitory Concentrations (MICs) for key pathogens.
  • Examination of clinical data regarding vancomycin-associated adverse events.

Main Results:

  • Vancomycin is a primary treatment for Methicillin-Resistant Staphylococcus aureus (MRSA) and other resistant Gram-positive infections.
  • Emerging vancomycin resistance, termed 'vancomycin creep,' is observed, with higher MICs correlating to increased therapeutic failure rates, even in Methicillin-Susceptible Staphylococcus aureus (MSSA).
  • Adverse events include Red Man syndrome, allergic reactions, bone marrow effects, and nephrotoxicity.

Conclusions:

  • Vancomycin remains a vital antibiotic, especially for MRSA infections.
  • Monitoring vancomycin MIC trends and managing potential toxicities are critical for preserving its efficacy.
  • Continued effectiveness hinges on controlling the development and spread of vancomycin resistance.